secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclaris Therapeutics, Inc. (ACRS)
CIK:        0001557746
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001104659-26-025420
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclaris Therapeutics raises $39.8M via ATM offering of 12.7M shares
-------------------------------------------------------------------

- Sold 12.7 million shares for gross proceeds of $39.8M under ATM agreement from March 2-9, 2026.
- Shares purchased by institutional investors including Deep Track Capital.
- Sales executed by agents Leerink Partners and Cantor Fitzgerald.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/0001104659-26-025420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1557746/000110465926025420/acrs-20260309x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-025420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer